Allopurinol to Prevent Cirrhosis Related Morbidities
NCT05545670
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Cirrhosis
Interventions
DRUG:
Placebo
DRUG:
Allopurinol 300 MG
Sponsor
Tanta University